WallStreetZenWallStreetZen

NYSEMKT: PTHS
Pelthos Therapeutics Inc Stock Ownership - Who owns Pelthos Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Pelthos Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Matthew PaulsDirector2026-07-0294$27.36
$2.57kSell
Ezra M. FriedbergDirector2026-07-02534$26.03
$13.90kSell
Ezra M. FriedbergDirector2026-07-0224$27.33
$655.80Sell
Peter GreenleafDirector2026-07-02712$26.00
$18.51kSell
Peter GreenleafDirector2026-07-0285$27.27
$2.32kSell
Matthew PaulsDirector2026-07-02692$26.00
$17.99kSell
Ezra M. FriedbergDirector2026-06-15224$27.13
$6.08kSell
Ezra M. FriedbergDirector2026-06-1559$27.94
$1.65kSell
Todd C. DavisDirector2026-06-11503$28.73
$14.45kBuy
Todd C. DavisDirector2026-06-1135,445$27.81
$985.55kBuy

1 of 3

PTHS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PTHS insiders and whales buy or sell their stock.

PTHS Shareholders

What type of owners hold Pelthos Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Todd C. Davis45.34%1,575,834$42.53MInsider
Ligand Pharmaceuticals Inc43.16%1,500,000$40.49MInsider
Ezra M. Friedberg20.83%723,833$19.54MInsider
Motif Pharmaceuticals Ltd13.54%470,674$12.70MInsider
Boswell Prayer Ltd13.23%459,895$12.41MInsider
Aperture Healthcare Ventures Ltd12.27%426,566$11.51MInsider
Ame Equities LLC10.10%351,163$9.48MInsider
Murchinson Ltd8.53%296,314$8.00MInstitution
Ikarian Capital LLC7.38%256,598$6.93MInstitution
Vanguard Capital Management LLC2.68%93,093$2.51MInstitution

1 of 3

PTHS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PTHS13.61%86.39%Net BuyingNet Buying
BMEA33.68%25.19%Net Buying
INO38.12%37.87%Net SellingNet Selling
VRCA14.80%85.20%Net Buying
SPRO36.38%62.50%Net SellingNet Selling
View Top Biotech Stocks

Pelthos Therapeutics Stock Ownership FAQ

Who owns Pelthos Therapeutics?

Pelthos Therapeutics (NYSEMKT: PTHS) is owned by 26.25% institutional shareholders, 166.63% Pelthos Therapeutics insiders, and 0.00% retail investors. Todd C. Davis is the largest individual Pelthos Therapeutics shareholder, owning 1.58M shares representing 45.34% of the company. Todd C. Davis's Pelthos Therapeutics shares are currently valued at $42.53M.

If you're new to stock investing, here's how to buy Pelthos Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.